Pharmabiz

AstraZeneca introduces next-gen cardiologists through India Coronary Conquest 2026 with STEMI

AstraZeneca introduces next-gen cardiologists through India Coronary Conquest 2026 with STEMI: Our Bureau, Bengaluru Tuesday, April 21, 2026, 15:30 Hrs [IST] AstraZeneca Pharma In ...
Pharmabiz

Asahi Kasei initiates phase I trial of AK1940, a novel peptide candidate targeting autoimmune diseases

Asahi Kasei initiates phase I trial of AK1940, a novel peptide candidate targeting autoimmune diseases: Tokyo Tuesday, April 21, 2026, 15:00 Hrs [IST] Asahi Kasei, a diversified g ...
Pharmabiz

Jeena Sikho Lifecare & Sat Kartar Life ink collaboration to build a technology-enabled Ayurveda healthcare ecosystem

Jeena Sikho Lifecare & Sat Kartar Life ink collaboration to build a technology-enabled Ayurveda healthcare ecosystem: Our Bureau, Mumbai Tuesday, April 21, 2026, 13:45 Hrs [IST] I ...
Pharmabiz

Orbicular's partner secures tentative US FDA approval for generic version of Ozempic

Orbicular's partner secures tentative US FDA approval for generic version of Ozempic: Our Bureau, Bengaluru Tuesday, April 21, 2026, 14:20 Hrs [IST] OneSource Specialty Pharma’s ...
Pharmabiz

US FDA grants priority review to sBLA for Padcev+Keytruda as perioperative treatment for muscle-invasive bladder cancer regardless of cisplatin eligibility

US FDA grants priority review to sBLA for Padcev+Keytruda as perioperative treatment for muscle-invasive bladder cancer regardless of cisplatin eligibility: Tokyo Tuesday, April 2 ...
Pharmabiz

CDSCO declares 168 drug samples as NSQs, one as spurious in March

CDSCO declares 168 drug samples as NSQs, one as spurious in March: Our Bureau, New Delhi Tuesday, April 21, 2026, 14:45 Hrs [IST] The Central Drugs Standard Control Organisation ( ...
Pharmabiz

CitiusTech appoints Shyam Karunakaran as chief business officer – Payers & Platform Solutions

CitiusTech appoints Shyam Karunakaran as chief business officer – Payers & Platform Solutions: Our Bureau, Mumbai Tuesday, April 21, 2026, 14:15 Hrs [IST] CitiusTech, a leading ...
Pharmabiz

Morepen Labs' Masulkhana facility clears US FDA inspection with Zero adverse observations

Morepen Labs' Masulkhana facility clears US FDA inspection with Zero adverse observations: Our Bureau, Mumbai Tuesday, April 21, 2026, 13:30 Hrs [IST] Morepen Laboratories Limited ...
Pharmabiz

Medtronic completes acquisition of medical device company, CathWorks

Medtronic completes acquisition of medical device company, CathWorks: Galway, Ireland Tuesday, April 21, 2026, 14:00 Hrs [IST] Medtronic plc, a global leader in healthcare technol ...
Pharmabiz

AstraZeneca’s pivotal phase III MIRANDA trial of tozorakimab to treat COPD meets primary endpoint

AstraZeneca’s pivotal phase III MIRANDA trial of tozorakimab to treat COPD meets primary endpoint: Cambridge, UK Positive high-level res ...
Pharmabiz

Asahi Kasei completes acquisition of Aicuris to advance its global pharmaceutical strategy

Asahi Kasei completes acquisition of Aicuris to advance its global pharmaceutical strategy: Tokyo Tuesday, April 21, 2026, 12:00 Hrs [IST] Asahi Kasei, a diversified global compan ...
Pharmabiz

India extends export RELIEF Scheme to Egypt and Jordan to cushion pharma trade amid West Asia disruptions

India extends export RELIEF Scheme to Egypt and Jordan to cushion pharma trade amid West Asia disruptions: Shardul Nautiyal, Mumbai Tuesday, April 21, 2026, 08:00 Hrs [IST] In a m ...